Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Child and Adolescent Psychiatric Clinics of North America|June 13, 2022
Nonstimulant Treatments for ADHDJeffrey H Newcorn, Beth Krone, Ralf W Dittmann
Journal of Attention Disorders|January 31, 2024
Effects of Stimulant Treatment on Changes in Brain Activation During Reward Notifications in Drug Naïve Youth With ADHDIliyan Ivanov, Beth Krone, Kurt Schulz, et al.
Frontiers in Child and Adolescent Psychiatry|January 16, 2025
Neuropsychological correlates of ADHD: indicators of different attentional profiles among youth with sluggish cognitive tempoBeth Krone, Anne-Claude V Bédard, Kurt Schulz, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|June 20, 2014
Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention-deficit/hyperactivity disorderAnne-Claude V Bédard, Mark A Stein, Jeffrey M Halperin, et al.
Frontiers in Child and Adolescent Psychiatry|January 22, 2025
Characteristics of Sluggish Cognitive Tempo among adults with ADHD: objective neurocognitive measures align with self-report of executive functionBeth Krone, Lenard A Adler, Deepti Anbarasan, et al.
Psychiatry Research|February 10, 2015
Neural mechanisms underlying the therapeutic actions of guanfacine treatment in youth with ADHD: a pilot fMRI studyAnne-Claude V Bédard, Kurt P Schulz, Beth Krone, et al.
The Journal of Clinical Psychiatry|July 7, 2021
A Placebo-Controlled Trial of Lisdexamfetamine in the Treatment of Comorbid Sluggish Cognitive Tempo and Adult ADHDLenard A Adler, Terry L Leon, Taylor M Sardoff, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|August 25, 2014
Reduced prefrontal efficiency for visuospatial working memory in attention-deficit/hyperactivity disorderAnne-Claude V Bédard, Jeffrey H Newcorn, Suzanne M Clerkin, et al.
Journal of Child and Adolescent Psychopharmacology|October 10, 2024
Dopamine Transporter and <i>CYP2D6</i> Gene Relationships with Attention-Deficit/Hyperactivity Disorder Treatment Response in the Methylphenidate and Atomoxetine Crossover StudyJeffrey R Bishop, Chuan Zhou, Andrea Gaedigk, et al.
Pageof 2